Back to Search
Kailera Therapeutics, Inc. (KLRA)
Ticker: KLRA
CIK: 0002096997
27
Filings Found (Last 1 Year)
Filter Filings
All
4
2026. 9. 7.
Nicholson Nur (CIK 0001827317)
Insider trading report
4
Open Filing
10-Q
2026. 6. 30.
Kailera Therapeutics, Inc. (KLRA) (CIK 0002096997)
Quarterly report
10-Q
Open Filing
8-K
2026. 8. 12.
Kailera Therapeutics, Inc. (KLRA) (CIK 0002096997)
Current report
8-K
Open Filing
4
2026. 7. 6.
Tregoning Kathleen (CIK 0001830764)
Insider trading report
4
Open Filing
4
2026. 6. 9.
Renaud Ronald C JR (CIK 0001354434)
Insider trading report
4
Open Filing
10-Q
2026. 3. 31.
Kailera Therapeutics, Inc. (KLRA) (CIK 0002096997)
Quarterly report
10-Q
Open Filing
8-K
2026. 5. 26.
Kailera Therapeutics, Inc. (KLRA) (CIK 0002096997)
Current report
8-K
Open Filing
4
2026. 4. 20.
RTW INVESTMENTS, LP (CIK 0001493215)
Insider trading report
Open Filing
4
2026. 4. 20.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CIK 0002080343)
Insider trading report
OWNERSHIP DOCUMENT
Open Filing
4
2026. 4. 20.
BAIN CAPITAL INVESTORS LLC (CIK 0001040508)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Koppel Adam (CIK 0001578965)
Insider trading report
4
Open Filing
4
2026. 4. 20.
Bain Capital Life Sciences Investors, LLC (CIK 0001703031)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Kaplan Andrew T. (CIK 0001752059)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Cloghessy Paula (CIK 0001744682)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Akamine Scott (CIK 0001816720)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Renaud Ronald C JR (CIK 0001354434)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Burgess Paul D. (CIK 0001744627)
Insider trading report
4
Open Filing
4
2026. 4. 16.
MILLIGAN JOHN F (CIK 0001191589)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Coleman Jamie Beth (CIK 0002118765)
Insider trading report
4
Open Filing
4
2026. 4. 16.
MACKAY MARTIN (CIK 0001414815)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Wasserman Scott M. (CIK 0002118767)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Hite Christopher (CIK 0001814238)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Clyburn Frank (CIK 0001763963)
Insider trading report
4
Open Filing
4
2026. 4. 16.
Pagan Douglas W. (CIK 0001628880)
Insider trading report
4
Open Filing
8-K
2026. 4. 20.
Kailera Therapeutics, Inc. (KLRA) (CIK 0002096997)
Current report
8-K
Open Filing
S-1/A
2026. 4. 13.
Kailera Therapeutics, Inc. (KLRA) (CIK 0002096997)
S-1/A
S-1/A
Open Filing
S-1
2026. 3. 27.
Kailera Therapeutics, Inc. (CIK 0002096997)
Registration statement
S-1
Open Filing
Previous
Page 3 of 2
Next
KLRA SEC Filings | SEC Document SEARCH